Works by Limmroth, Volker


Results: 51
    1
    2
    3
    4

    Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy.

    Published in:
    Annals of Neurology, 2014, v. 76, n. 6, p. 792, doi. 10.1002/ana.24153
    By:
    • Warnke, Clemens;
    • Geldern, Gloria;
    • Markwerth, Philipp;
    • Dehmel, Thomas;
    • Hoepner, Robert;
    • Gold, Ralf;
    • Pawlita, Michael;
    • Kümpfel, Tania;
    • Mäurer, Mathias;
    • Stangel, Martin;
    • Wegner, Florian;
    • Hohlfeld, Reinhard;
    • Straeten, Vera;
    • Limmroth, Volker;
    • Weber, Thomas;
    • Hermsen, Derik;
    • Kleinschnitz, Christoph;
    • Hartung, Hans‐Peter;
    • Wattjes, Mike P.;
    • Svenningson, Anders
    Publication type:
    Article
    5
    6

    Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies.

    Published in:
    Multiple Sclerosis Journal, 2020, v. 26, n. 14, p. 1866, doi. 10.1177/1352458519888610
    By:
    • Comi, Giancarlo;
    • Alroughani, Raed;
    • Boster, Aaron L;
    • Bass, Ann D;
    • Berkovich, Regina;
    • Fernández, Óscar;
    • Kim, Ho Jin;
    • Limmroth, Volker;
    • Lycke, Jan;
    • Macdonell, Richard AL;
    • Sharrack, Basil;
    • Singer, Barry A;
    • Vermersch, Patrick;
    • Wiendl, Heinz;
    • Ziemssen, Tjalf;
    • Jacobs, Alan;
    • Daizadeh, Nadia;
    • Rodriguez, Claudio E;
    • Traboulsee, Anthony;
    • Baker, Darren P.
    Publication type:
    Article
    7

    Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF.

    Published in:
    Multiple Sclerosis Journal, 2015, v. 21, n. 8, p. 1036, doi. 10.1177/1352458514556296
    By:
    • Warnke, Clemens;
    • Stettner, Mark;
    • Lehmensiek, Vera;
    • Dehmel, Thomas;
    • Mausberg, Anne K.;
    • Von Geldern, Gloria;
    • Gold, Ralf;
    • Kümpfel, Tania;
    • Hohlfeld, Reinhard;
    • Mäurer, Mathias;
    • Stangel, Martin;
    • Straeten, Vera;
    • Limmroth, Volker;
    • Weber, Thomas;
    • Kleinschnitz, Christoph;
    • Wattjes, Mike P.;
    • Svenningsson, Anders;
    • Olsson, Tomas;
    • Hartung, Hans-Peter;
    • Hermsen, Derik
    Publication type:
    Article
    8

    Anti-JC-virus antibody prevalence in a German MS cohort.

    Published in:
    2012
    By:
    • Warnke, Clemens;
    • Dehmel, Thomas;
    • Posevitz-Fejfár, Anita;
    • Chan, Andrew;
    • Berthele, Achim;
    • Schmidt, Stephan;
    • Haas, Judith;
    • Kronsbein, Helena C;
    • Seitz, Florian;
    • Tackenberg, Björn;
    • Mäurer, Mathias;
    • Gerbershagen, Kathrin;
    • Limmroth, Volker;
    • Adams, Ortwin;
    • Hartung, Hans-Peter;
    • Gold, Ralf;
    • Hemmer, Bernhard;
    • Wiendl, Heinz;
    • Kieseier, Bernd C
    Publication type:
    Letter
    9

    Effect of BG-12 on contrast-enhanced lesions in patients with relapsing– remitting multiple sclerosis: subgroup analyses from the phase 2b study.

    Published in:
    Multiple Sclerosis Journal, 2012, v. 18, n. 3, p. 314, doi. 10.1177/1352458511421054
    By:
    • Kappos, Ludwig;
    • Gold, Ralf;
    • Miller, David H;
    • MacManus, David G;
    • Havrdova, Eva;
    • Limmroth, Volker;
    • Polman, Chris H;
    • Schmierer, Klaus;
    • Yousry, Tarek A;
    • Eraksoy, Mefkure;
    • Meluzinova, Eva;
    • Dufek, Michal;
    • Yang, Minhua;
    • Dawson, Kate;
    • O’Neill, Gilmore N
    Publication type:
    Article
    10
    11

    Quality Assessment in Multiple Sclerosis Therapy (QUASIMS).

    Published in:
    Journal of Neurology, 2007, v. 254, n. 1, p. 67, doi. 10.1007/s00415-006-0281-1
    By:
    • Limmroth, Volker;
    • Malessa, Rolf;
    • Zettl, Uwe Klaus;
    • Koehler, Jürgen;
    • Japp, Gudrun;
    • Haller, Peter;
    • Elias, Wolfgang;
    • Obhof, Winfried;
    • Viehöver, Andrea;
    • Meier, Uwe;
    • Brosig, Arne;
    • Hasford, Joerg;
    • Putzki, Norman;
    • Kalski, Gabriele;
    • Wernsdörfer, Colin
    Publication type:
    Article
    12
    13
    14
    15
    16

    Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study.

    Published in:
    2020
    By:
    • Ziemssen, Tjalf;
    • Bass, Ann D.;
    • Berkovich, Regina;
    • Comi, Giancarlo;
    • Eichau, Sara;
    • Hobart, Jeremy;
    • Hunter, Samuel F;
    • LaGanke, Christopher;
    • Limmroth, Volker;
    • Pelletier, Daniel;
    • Pozzilli, Carlo;
    • Schippling, Sven;
    • Sousa, Livia;
    • Traboulsee, Anthony;
    • Uitdehaag, Bernard M. J.;
    • Van Wijmeersch, Bart;
    • Choudhry, Zia;
    • Daizadeh, Nadia;
    • Singer, Barry A.;
    • CARE-MS I, CARE-MS II, CAMMS03409, and TOPAZ investigators
    Publication type:
    journal article
    17
    18
    19

    Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation.

    Published in:
    Journal of Neurology, 2019, v. 266, n. 1, p. 165, doi. 10.1007/s00415-018-9117-z
    By:
    • Pfeuffer, Steffen;
    • Schmidt, Rene;
    • Straeten, Frederike Anne;
    • Pul, Refik;
    • Kleinschnitz, Christoph;
    • Wieshuber, Marinus;
    • Lee, De-Hyung;
    • Linker, Ralf A.;
    • Doerck, Sebastian;
    • Straeten, Vera;
    • Windhagen, Susanne;
    • Pawlitzki, Marc;
    • Aufenberg, Christoph;
    • Lang, Michael;
    • Eienbroeker, Christian;
    • Tackenberg, Björn;
    • Limmroth, Volker;
    • Wildemann, Brigitte;
    • Haas, Jürgen;
    • Klotz, Luisa
    Publication type:
    Article
    20

    Alemtuzumab as rescue therapy in a cohort of 50 relapsing-remitting MS patients with breakthrough disease on fingolimod: a multi-center observational study.

    Published in:
    Journal of Neurology, 2018, v. 265, n. 7, p. 1521, doi. 10.1007/s00415-018-8871-2
    By:
    • Huhn, Konstantin;
    • Bayas, Antonios;
    • Doerck, Sebastian;
    • Frank, Benedikt;
    • Gerbershagen, Kathrin;
    • Hellwig, Kerstin;
    • Kallmann, Boris;
    • Kleinschnitz, Christoph;
    • Kleiter, Ingo;
    • Lee, De-Hyung;
    • Limmroth, Volker;
    • Mäurer, Mathias;
    • Meuth, Sven;
    • Rieckmann, Peter;
    • Ruck, Tobias;
    • Gold, Ralf;
    • Linker, Ralf A.
    Publication type:
    Article
    21
    22
    23

    Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings.

    Published in:
    Frontiers in Neurology, 2019, p. N.PAG, doi. 10.3389/fneur.2019.00253
    By:
    • Barclay, Krista;
    • Carruthers, Robert;
    • Traboulsee, Anthony;
    • Bass, Ann D.;
    • LaGanke, Christopher;
    • Bertolotto, Antonio;
    • Boster, Aaron;
    • Celius, Elisabeth G.;
    • Seze, Jérôme de;
    • Cruz, Dionisio Dela;
    • Habek, Mario;
    • Lee, Jong-Mi;
    • Limmroth, Volker;
    • Meuth, Sven G.;
    • Oreja-Guevara, Celia;
    • Pagnotta, Patricia;
    • Vos, Cindy;
    • Ziemssen, Tjalf;
    • Baker, Darren P.;
    • Wijmeersch, Bart Van
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Pain Therapy in German Neurology.

    Published in:
    European Neurology, 2008, v. 60, n. 4, p. 167, doi. 10.1159/000148243
    By:
    • Gerbershagen, Kathrin;
    • Limmroth, Volker
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    (DMT02) Yearly Efficacy and Safety Outcomes Over 4 Years After Last Alemtuzumab Course in Pooled CAREMS I and II Patients by Number of Additional Courses Received Through Year 9.

    Published in:
    International Journal of MS Care, 2020, v. 22, n. S2, p. 4
    By:
    • Berkovich, Regina;
    • Alroughani, Raed;
    • Bass, Ann D.;
    • Boster, Aaron L.;
    • Comi, Giancarlo;
    • Ho Jin Kim;
    • Limmroth, Volker;
    • Lycke, Jan;
    • Macdonell, Richard A. L.;
    • Schippling, Sven;
    • Sharrack, Basil;
    • Tintoré, Mar;
    • Traboulsee, Anthony;
    • Vermersch, Patrick;
    • Wiendl, Heinz;
    • Ziemssen, Tjalf;
    • Daizadeh, Nadia;
    • Jacobs, Alan;
    • Poole, Elizabeth M.;
    • Singer, Barry A.
    Publication type:
    Article
    47
    48
    49
    50